POMC and nephrotic syndrome: In 2004, Berg and Arnadottir reported that synthetic ACTH, 0.75–1 mg twice weekly for nine months, allowed to achieve complete remission in 15 patients with MN and nephrotic syndrome, which was sustained for up to 18–30 months in 14 patients (59).